
Large research infrastructures, a chemical and paper industry supporting a sector that is considered strategic, clusters that are able to build extended value chains, universities at the level of excellence and a federal government and provinces with a vision and an effective action plan. These are shortly all the strengths of the bioeconomy in Canada, as I saw them last week.
Comet Biorefining, the Canadian company focused on the production of high-purity cellulosic dextrose, completed a round of equity financing led by new investor PM Equity Partner. Current investor Sofinnova Partners and new investor Bioindustrial Innovation Canada (BIC) also participated in the financing, whose terms were not disclosed.

